Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma
| Class:Id | LiteratureReference:9765712 |
| _displayName | Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma |
| _timestamp | 2022-02-16 15:56:48 |
| author | [Person:9765722] Dai, Xiaoyun [Person:9765713] Ahn, Kwang Seok [Person:9765716] Wang, Ling Zhi [Person:9765718] Kim, Chulwon [Person:9765723] Deivasigamni, Amudha [Person:9708920] Arfuso, Frank [Person:9765711] Um, Jae-Young [Person:9765719] Kumar, Alan Prem [Person:9765721] Chang, Young-Chae [Person:9765717] Kumar, Dhiraj [Person:8856662] Kundu, Gopal C [Person:9765715] Magae, Junji [Person:9674462] Goh, Boon Cher [Person:9765720] Hui, Kam Man [Person:9708923] Sethi, Gautam |
| created | [InstanceEdit:9765724] Orlic-Milacic, Marija, 2022-02-16 |
| journal | Mol Cancer Ther |
| pages | 2966-2976 |
| pubMedIdentifier | 27765853 |
| title | Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma |
| volume | 15 |
| year | 2016 |
| (literatureReference) | [Reaction:9765710] STAT3 binds SNAI1 gene promoter [Homo sapiens] [Reaction:9765714] STAT3 stimulates SNAI1 gene expression [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma (9765712)